UnknownPhase 1NCT00278707

GTA-Glyceryltriacetate for Canavan Disease

Studying Canavan disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sheba Medical Center
Principal Investigator
Yair Anikster, MD PI
Director Metabolic Disease Unit
Intervention
GTA: Glyceryltriacetate(drug)
Enrollment
5 enrolled
Eligibility
0 years · All sexes
Timeline
2006 – 2006

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00278707 on ClinicalTrials.gov

Other trials for Canavan disease

Additional recruiting or active studies for the same condition.

See all trials for Canavan disease →

← Back to all trials